Company / Gross Profit per Share
Protalix BioTherapeutics, Inc. Gross Profit per Share History
FY2015-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$0.03
FY2017
5-year range
-
FY2015-FY2017
Trend
+1.0%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.00 to $0.03 over the past 2 years.
Based on SEC 10-K filings.
0.03 in FY2017.
Improved from $0.00 to $0.03 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, gross profit per share increased 1.0% year-over-year.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2017 | $0.03 | +1.0% |
| FY2016 | $0.03 | - |
| FY2015 | $0.00 | -100.0% |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026